Home > Insider Trading > Filing (0001562180-21-005842)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1603756	Axonics Inc.	AXNX	Surgical & Medical Instruments & Apparatus (3841)	454744083

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1756437	John Woock	26 Technology Drive Irvine CA 92618	Chief Marketing Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-01	5,000	$1.63	34,932	No	4	M	Direct
Common Stock	Disposition	2021-09-01	8,443	$74.73	26,489	No	4	S	Direct
Common Stock	Disposition	2021-09-02	1,557	$75.58	24,932	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-09-01	3,443	$0.00	3,443	$1.63
Common Stock	Stock Option (Right to Buy)	Disposition	2021-09-02	1,557	$0.00	1,557	$1.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,757		2028-03-30	No	4	M	Direct
11,200		2028-03-30	No	4	M	Direct

Footnotes

This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 15, 2021.
This transaction was executed in multiple trades at prices ranging from $73.82 to $75.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $75.00 to $76.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares subject to the option vest over a period of four years. 7,800 of the shares subject to the option vested on March 30, 2018 and the remainder vest at a rate of 1/36th per month commencing on March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.